# Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide

> **NCT00823628** · PHASE4 · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 420 (estimated)

## Conditions studied

- Chronic Renal Insufficiency
- Coronary Angiography

## Interventions

- **DRUG:** contrast agent (iopromide)
- **DRUG:** contrast agent (iodixanol)

## Key facts

- **NCT ID:** NCT00823628
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-05
- **Final completion:** 2010-06
- **Target enrollment:** 420 (ESTIMATED)
- **Last updated:** 2010-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00823628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00823628, "Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00823628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*